Vimarsana
Biggest News Aggregation in the World

Page 3 - Testing Products News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Testing Products. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Testing Products Today - Breaking & Trending Today

Point of Care & Rapid Diagnostics Market worth $72.0 billion by 2027 - Exclusive Report by MarketsandMarkets - Vimarsana News

Point of Care & Rapid Diagnostics Market worth $72.0 billion by 2027 - Exclusive Report by MarketsandMarkets

CHICAGO, March 8, 2022 /PRNewswire/ -- According to the new market research report "Point of Care and Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C), Pregnancy

Point of Care & Rapid Diagnostics Market worth $72.0 billion by 2027 - Exclusive Report by MarketsandMarkets™ - Vimarsana News

Point of Care & Rapid Diagnostics Market worth $72.0 billion by 2027 - Exclusive Report by MarketsandMarkets™

/PRNewswire/ -- According to the new market research report "Point of Care and Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis...

Investegate |Abingdon Health PLC Announcements | Abingdon Health PLC: Update on AffiDX SARS-CoV-2 antigen LFT - Vimarsana News

Investegate |Abingdon Health PLC Announcements | Abingdon Health PLC: Update on AffiDX SARS-CoV-2 antigen LFT

Investegate announcements from Abingdon Health PLC, Update on AffiDX� SARS-CoV-2 antigen LFT

Mycoplasma Testing Market Is Projected to Reach $1.59 Billion by 2027 | CAGR: 12.8%: Polaris Market Research - Vimarsana News

Mycoplasma Testing Market Is Projected to Reach $1.59 Billion by 2027 | CAGR: 12.8%: Polaris Market Research

kits and reagents segment dominated the market with its largest revenue share contribution, owing to the increasing use of consumables for mycoplasma analysis while conducting cell culture research work and related activities. In terms of technology, the Polymerase Chain Reaction (PCR) segment held the majority of the market share and is expected to constitute more than half of the market over the forecast period. High specificity, efficiency, and preciseness are some of the key attributes that make PCR ideal for mycoplasma analysis. Pharmaceutical & biotechnology companies market segmen...

2020 Study on Products in Sepsis Diagnostics - Major Products on the Market - Vimarsana News

2020 Study on Products in Sepsis Diagnostics - Major Products on the Market

Share this article Share this article ResearchAndMarkets.com's offering. The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently. In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths. Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals. This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Markets for Sepsis-Related Testing COVID-19 and Sepsis Sepsis Testing Pro...